- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Results
4
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
4 companies
PharmaEngine
Market Cap: NT$10.9b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$75.40
7D
1.9%
1Y
-23.2%
TTY Biopharm
Market Cap: NT$18.5b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$74.80
7D
0.5%
1Y
-1.7%
Lotus Pharmaceutical
Market Cap: NT$55.9b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$216.00
7D
3.3%
1Y
-25.8%
Bora Pharmaceuticals
Market Cap: NT$84.2b
Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.
6472
NT$818.00
7D
4.2%
1Y
-14.3%